Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen

Marta Gómez-García de la Banda1,2,3, Alessandro Amaddeo4,5, Sonia Khirani4,5,6

  • 1Pediatric Neurology and ICU Department, AP-HP Université Paris Saclay, DMU Santé de l'Enfant et de l'Adolescent, Hôpital Raymond Poincaré, Garches, France.

Pediatric Pulmonology
|October 29, 2020
PubMed

Insights

Nusinersen treatment significantly improved respiratory muscle strength and lung function in children with Spinal Muscular Atrophy (SMA) Type 2. Motor function also showed improvement, offering new hope for SMA patients.

Area of Science:

  • Neurology
  • Pediatrics
  • Pulmonology

Background:

  • Spinal Muscular Atrophy (SMA) is a genetic disorder affecting motor neurons.
  • Nusinersen improves motor function in SMA but its effect on respiratory muscles is less understood.
  • Respiratory muscle weakness is a major concern in SMA patients.

Purpose of the Study:

  • To evaluate the impact of nusinersen on respiratory muscle performance and lung function in children with SMA Types 1c and 2.
  • To compare respiratory muscle strength in nusinersen-treated SMA Type 2 patients with historical controls.

Main Methods:

  • 16 children with SMA (2 Type 1c, 14 Type 2) received six nusinersen injections.
  • Respiratory muscle strength was assessed using maximal static inspiratory pressure, forced vital capacity, and esophageal pressure.
  • Motor function was evaluated using the Motor Function Measurement (MFM) and Hammersmith-Hine Scale (HINE-2) at baseline and 14 months.
  • Data from treated SMA Type 2 patients were compared to 14 age-matched historical controls.

Main Results:

  • Nusinersen-treated SMA Type 2 patients showed significantly improved inspiratory muscle strength compared to historical controls (p < .05).
  • Improvements were noted in maximal static inspiratory pressure, forced vital capacity, and esophageal pressure during maximal sniff.
  • Significant improvements in MFM and HINE-2 scores were observed in all 16 SMA patients after 14 months of nusinersen treatment.

Conclusions:

  • Nusinersen treatment leads to significant improvements in respiratory muscle performance in children with SMA Type 2.
  • The study demonstrates a positive effect of nusinersen on both respiratory and motor functions in pediatric SMA patients.
Abstract

Related Concept Videos

Assessment of Airway, Skin Color, and Use of Accessory Muscles01:30

Assessment of Airway, Skin Color, and Use of Accessory Muscles

A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
1.4K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.5K
Assessment of Respiration01:23

Assessment of Respiration

The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
1.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
772
Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
692